Argent Capital Management LLC Has $2.21 Million Holdings in CorVel Corp. $CRVL

Argent Capital Management LLC boosted its position in CorVel Corp. (NASDAQ:CRVL) by 52.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,531 shares of the business services provider’s stock after purchasing an additional 13,930 shares during the quarter. Argent Capital Management LLC owned about 0.08% of CorVel worth $2,215,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CRVL. Northwestern Mutual Wealth Management Co. bought a new stake in shares of CorVel in the third quarter valued at approximately $31,000. Los Angeles Capital Management LLC bought a new position in CorVel during the 4th quarter worth $33,000. Eagle Bay Advisors LLC acquired a new position in CorVel in the 4th quarter valued at $37,000. Rockefeller Capital Management L.P. raised its holdings in CorVel by 66.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock valued at $39,000 after acquiring an additional 230 shares in the last quarter. Finally, Quarry LP lifted its position in shares of CorVel by 218.6% during the 3rd quarter. Quarry LP now owns 513 shares of the business services provider’s stock valued at $40,000 after acquiring an additional 352 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at CorVel

In other news, VP Jennifer Yoss sold 1,999 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $61.02, for a total value of $121,978.98. Following the completion of the transaction, the vice president directly owned 2,173 shares in the company, valued at approximately $132,596.46. This represents a 47.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Maxim Shishin sold 2,250 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $60.59, for a total value of $136,327.50. Following the sale, the insider owned 7,050 shares in the company, valued at $427,159.50. This represents a 24.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 13,249 shares of company stock worth $807,126. Corporate insiders own 39.72% of the company’s stock.

CorVel Trading Up 1.0%

Shares of CorVel stock opened at $60.06 on Friday. The firm’s 50 day moving average is $61.03 and its 200 day moving average is $58.12. The firm has a market capitalization of $3.06 billion, a PE ratio of 28.07 and a beta of 0.98. CorVel Corp. has a 1 year low of $44.83 and a 1 year high of $93.71.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, May 19th. The business services provider reported $0.61 EPS for the quarter. CorVel had a net margin of 11.51% and a return on equity of 29.92%. The business had revenue of $248.55 million during the quarter.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CRVL shares. Weiss Ratings raised CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 16th. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).